The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on the Henry Ford Health System. [electronic resource]
Producer: 20011101Description: 21-3 p. digitalISSN:- 1096-5645
- Anti-Ulcer Agents -- economics
- Decision Making, Organizational
- Delivery of Health Care, Integrated -- economics
- Drug Costs
- Enzyme Inhibitors -- economics
- Formularies as Topic
- Gastroesophageal Reflux -- drug therapy
- Humans
- Institutional Management Teams
- Michigan
- Organizational Policy
- Proton Pump Inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.